Bristol Myers Squibb (BMY.N) CEO Christopher Boerner said on Monday the drugmaker expects to add 16 new products to its portfolio by the end of the decade.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
